Table 1. Demographic and treatment characteristics.
| Entire cohort | Stable after initial treatment | Recurrent or progressive tumor | |
|---|---|---|---|
| All patients | 28 | 15 (54 %) | 13 (46 %) |
| Age at Dx (n = 28) | |||
| Mean (range) | 30 (5–61) | 31 (20–53) | 28 (5–61) |
| Gender (n = 28) | |||
| Male | 15 (54 %) | 10 | 5 |
| Female | 13 (46 %) | 5 | 8 |
| Size by MRI imaging (largest dimension in cm) (n = 27) | |||
| Mean (range) | 4.4 (0.8–8.6) | 4.1 (0.8–7.0) | 4.8 (2.5–8.6) |
| Median | 4.1 | 4.1 | 4.4 |
| Resection extent ± adjuvant radiotherapy (n = 28) | |||
| GTR (all) | 9 | 5 | 4 |
| GTR + adjuvant RT | 1 | 1 | 0 |
| GTR – adjuvant RT | 8 | 4 | 4 |
| STR (all) | 19 | 10 | 9 |
| STR + adjuvant RT | 3 | 3 | 0 |
| STR – adjuvant RT | 16 | 7 | 9 |
| Tumor MIB-1 index (percentage) (n = 24) | |||
| Mean (range) | 3.5 (0.5–7.7) | 2.7 (1.0–7.0) | 4.5 (0.5–7.7) |
| Median | 3.2 | 2.0 | 4.8 |
| Required VP shunting | 11 (38 %) | 5 | 6 |